Evidence map›Paper›PMID 16712478›Full record

ReviewCurrent molecular medicine2006

Toll-like receptors and corneal innate immunity.

Ashok Kumar, Fu-Shin X Yu

Abstract readReview
In one paragraph

Review in Current molecular medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. The NLRP1 Inflammasome Induces Pyroptosis in Human Corneal Epithelial Cells.Investigative ophthalmology & visual science · 2022
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. The cereus matter of Bacillus endophthalmitis.Experimental eye research · 2020
    Review
  19. Frontiers in immunology · 2020
    Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ashok KumarThe Kresge Eye Institute/Department of Ophthalmology, Wayne State University School of Medicine, Detroit, MI 48201, USA. akuma@med.wayne.edu
Fu-Shin X Yu

Funding

MOLECULAR REGULATION OF CORNEAL WOUND HEALINGR01EY010869 · NEI · WAYNE STATE UNIVERSITY · PI YU, FU-SHIN X · 1995 to 2023
$7.7M
Epithelial Barrier During Corneal InfectionR01EY014080 · NEI · WAYNE STATE UNIVERSITY · PI YU, FU-SHIN X · 2001 to 2004
$1.2M
NEI NIH HHS EY10869NEI NIH HHS R01 EY010869NEI NIH HHS R01 EY014080NEI NIH HHS R01-EY14080
6 · The paper itself

Abstract

The ocular surface is constantly exposed to a wide array of microorganisms. The ability of the cornea to recognize pathogens as foreign and eliminate them is critical to retain its transparency, hence preservation of sight. In the eye, as in other parts of the body, the early response against invading pathogens is provided by innate immunity. Corneal innate immune system uses a series of pattern recognition receptors to detect the presence of pathogens thus allowing for rapid host defense responses to invading microbes. A key component of such receptors is the "Toll-like receptors" (TLRs), which have come to occupy the center stage in innate immunity against invading pathogens. An increasing number of studies have shown that TLRs are expressed by a variety of tissues and cells of the eye and play an important role in ocular defense against microbial infection. Here in this review we summarize the current knowledge about TLR expression in human eye with main emphasis on the cornea, and discuss the future directions of the field.

Indexed as

AnimalsCorneaHumansImmunity, ActiveImmunity, InnateModels, BiologicalSignal TransductionToll-Like ReceptorsToll-Like Receptors

Identifiers

PMID16712478
PMCPMC2666391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.